| Gufic BioSciences Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 509079 |
NSE Symbol : GUFICBIO |
P/E(TTM) : 46.49 |
|
ISIN Demat : INE742B01025 |
Div & Yield% : 0.02 |
EPS(TTM) : 8.61 |
|
Book Value(₹) : 53.11 |
Market Cap(₹Cr) : 4,013.61 |
Face Value(₹) : 1.00 |
| Particulars | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | 806.67 | 690.62 | 779.16 | 487.70 | 378.84 |
| Excise Duty | - | - | - | - | - |
| Net Sales | 806.67 | 690.62 | 779.16 | 487.70 | 378.84 |
| Other Income | 2.18 | 2.57 | 3.10 | 3.73 | 5.79 |
| Stock Adjustments | -0.57 | 33.39 | 19.39 | -14.29 | 10.91 |
| Total Income | 808.28 | 726.58 | 801.65 | 477.14 | 395.54 |
| EXPENDITURE : | |||||
| Raw Materials | 389.32 | 365.21 | 431.35 | 236.00 | 190.45 |
| Power and Fuel Cost | 17.79 | 15.24 | 11.00 | 9.94 | 8.23 |
| Other Manufacturing Expenses | 28.43 | 24.67 | 27.42 | 18.20 | 15.93 |
| Selling and Administration Expenses | 104.31 | 87.63 | 77.97 | 45.93 | 54.08 |
| Miscellaneous Expenses | 10.75 | 9.88 | 17.16 | 13.20 | 10.35 |
| Employee Benefit Expenses | 109.63 | 86.73 | 85.61 | 66.22 | 58.59 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 148.05 | 137.22 | 151.14 | 87.65 | 57.90 |
| Interest | 15.36 | 8.22 | 5.37 | 13.63 | 13.91 |
| Gross Profit | 132.69 | 129.00 | 145.77 | 74.02 | 43.99 |
| Depreciation | 17.02 | 22.28 | 18.93 | 16.31 | 13.86 |
| Profit Before Tax | 115.67 | 106.72 | 126.84 | 57.71 | 30.13 |
| Current Tax | 26.37 | 28.21 | 32.15 | 17.20 | 8.31 |
| Fringe Benefit tax | - | - | - | - | - |
| Deferred Tax | 3.17 | -1.19 | -1.15 | -3.72 | -0.87 |
| Reported Net Profit | 86.14 | 79.70 | 95.84 | 44.23 | 22.69 |
| Extraordinary Items | -1.67 | 0.02 | 0.05 | 0.02 | 0.01 |
| Adjusted Net Profit | 87.81 | 79.68 | 95.79 | 44.21 | 22.68 |
| Adjustment below Net Profit | - | - | - | 0.26 | - |
| Profit/Loss Balance carried down | 267.29 | 188.55 | 93.68 | 49.58 | 27.36 |
| Statutory Appropriations | - | - | - | - | - |
| Appropriations | 0.97 | 0.97 | 0.97 | 0.39 | 0.47 |
| P & L Balance carried down | 352.46 | 267.29 | 188.55 | 93.68 | 49.58 |
| Dividend | - | - | - | - | - |
| Preference Dividend | - | - | - | - | - |
| Equity Dividend (%) | 10.00 | 10.00 | 10.00 | 10.00 | 5.00 |
| Dividend Per Share(Rs) | 0.10 | 0.10 | 0.10 | 0.10 | 0.05 |
| Earnings Per Share-Unit Curr | 8.59 | 8.22 | 9.89 | 4.56 | 2.34 |
| Earnings Per Share(Adj)-Unit Curr | 8.59 | 8.22 | 9.89 | 4.56 | 2.34 |
| Book Value | 53.11 | 35.88 | 27.76 | 17.89 | 13.34 |
| Book Value(Adj)-Unit Curr | 53.11 | 35.88 | 27.76 | 17.89 | 13.34 |